highperformr logo

AXIM's Overview

Total employees212
HeadquartersSan Diego
Founded1998

Axim Biotechnologies, Inc. (OTCPK: AXIM) is an innovative biotechnology company dedicated to the research, development, and commercialization of proprietary diagnostic tools. The company's primary mission is to address unmet medical needs by developing novel, accurate, and rapid diagnostic solutions, with a significant focus on ophthalmology, particularly Dry Eye Disease (DED). Axim aims to improve patient outcomes through early and precise disease detection and management, leveraging its expertise in biomarker analysis and assay development.

Where is AXIM's Headquarters?

AXIM officeAXIM officeAXIM officeAXIM office
*Images sourced via web search. Rights belong to original owners

HQ Function

The San Diego headquarters serves as the company's main operational center, overseeing corporate strategy, research and development programs, clinical trial management, business development, and administrative functions.

Notable Features:

Located in the Sorrento Valley biotech cluster, the headquarters benefits from proximity to leading research institutions, a skilled talent pool, and a vibrant ecosystem of innovative companies. The facility likely comprises modern office space and potentially specialized laboratory areas for R&D activities.

Work Culture:

Axim Biotechnologies likely fosters a dynamic and innovative work environment, characterized by scientific rigor, collaboration, and a strong focus on achieving breakthroughs in medical diagnostics. The culture would emphasize agility and a patient-centric approach, typical of biotech firms driving new healthcare solutions.

HQ Significance:

The headquarters' location in San Diego is strategically vital, providing Axim access to world-class research facilities, potential partnerships, and investment opportunities crucial for a company in the competitive biotech sector.

Values Reflected in HQ: The headquarters' operations and strategic location reflect Axim's commitment to innovation, scientific excellence, collaboration, and the pursuit of impactful healthcare solutions.

Location:

While Axim Biotechnologies is headquartered in the USA, its diagnostic products and research initiatives have global relevance. The company's global presence is primarily manifested through its pursuit of international patents, engagement in clinical trials that may span multiple countries to ensure diverse population data and meet various regulatory standards, and strategic planning for future commercialization of its diagnostic tools in key markets worldwide. Its collaborations may also extend to international research institutions and partners.

Street Address:

10655 Sorrento Valley Rd, Suite 200

City:

San Diego

State/Province:

CA

Country:

USA

AXIM's Global Presence

N/A - Operations Primarily Centralized

Address: N/A

The company focuses on leveraging the rich biotech ecosystem of San Diego for its primary functions. Any international activities are typically project-specific rather than managed through dedicated regional offices.

Buying Intent Signals for AXIM

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of AXIM

As of April 2025, AXIM' leadership includes:

John W. Huemoeller II - Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer
Sergei Svarchevsky, PhD - Chief Scientific Officer
Joost J. Oppenheim, MD, PhD - Chief Medical Officer

Investors of AXIM

AXIM has been backed by several prominent investors over the years, including:

Publicly Traded (OTCPK: AXIM) - Primary funding through public shareholders and private placements.
Key insiders and management may also be significant shareholders.

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits0

Over the past year, Axim Biotechnologies has focused on strengthening its scientific and clinical leadership team with key appointments, including a new Chief Medical Officer. There have been no publicly announced C-suite executive departures during this period.

New Appointments:

Joost J. Oppenheim, MD, PhD, Axim Biotechnologies appointed Dr. Joost J. Oppenheim as Chief Medical Officer, enhancing the company's capabilities in clinical trial design and execution for its diagnostic products.

Technology (Tech Stack) used by AXIM

Discover the tools AXIM uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

AXIM Email Formats and Examples

Axim Biotechnologies likely utilizes standard corporate email address formats. A common pattern involves combining the employee's first initial and last name, followed by the company's domain.

[first_initial][last]@aximbiotech.com (e.g., jsmith@aximbiotech.com)

Format

jhuemoeller@aximbiotech.com

Example

75%

Success rate

News and media

GlobeNewswireMarch 26, 2024

AXIM® Biotechnologies Files Two Provisional Patent Applications for its Novel Quantitative Rapid Diagnostic Assay for Matrix Metalloproteinase-9 (MMP-9), an Inflammatory Biomarker for Dry Eye Disease

Axim Biotechnologies announced the filing of two new provisional patent applications for its innovative rapid diagnostic assay. This assay is designed to quantify levels of MMP-9, a key inflammatory biomarker for Dry Eye Disease, aiming to improve the diagnosis and management of the condition....more

GlobeNewswireMarch 20, 2024

AXIM® Biotechnologies Appoints Dr. Hories Fung and Dr. Thomas Stoss as Scientific Advisors

Axim Biotechnologies strengthened its scientific advisory board with the appointments of Dr. Hories Fung and Dr. Thomas Stoss. Their expertise in ophthalmology and diagnostic development will support the company's ongoing research programs and product development pipeline....more

GlobeNewswireNovember 29, 2023

AXIM® Biotechnologies Appoints Joost J. Oppenheim, MD, PhD as Chief Medical Officer

Axim Biotechnologies announced the appointment of Dr. Joost J. Oppenheim as its new Chief Medical Officer. Dr. Oppenheim will be responsible for leading the company's clinical development strategies, medical affairs, and providing oversight for clinical trials....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including AXIM, are just a search away.